HEARTS in the Americas

Regulatory Pathway to the Exclusive Use of Validated Blood Pressure Measuring Devices

Paperback
December 2021
9789275124857
More details
  • Publisher
    Pan American Health Organization
  • Published
    15th December 2021
  • ISBN 9789275124857
  • Language English
  • Pages 34 pp.
  • Size 8.5" x 11"
$25.00
Lib E-Book

Library E-Books

We are signed up with aggregators who resell networkable e-book editions of our titles to academic libraries. These editions, priced at par with simultaneous hardcover editions of our titles, are not available direct from Stylus.

These aggregators offer a variety of plans to libraries, such as simultaneous access by multiple library patrons, and access to portions of titles at a fraction of list price under what is commonly referred to as a "patron-driven demand" model.

December 2021
9789275124864
More details
  • Publisher
    Pan American Health Organization
  • Published
    15th December 2021
  • ISBN 9789275124864
  • Language English
  • Pages 34 pp.
  • Size 8.5" x 11"
$25.00

Cardiovascular disease (CVD) is the leading cause of disease burden globally. According to the 2017 Global Burden of Disease estimates, there were 14 million new cases of CVD, 80 million people living with this condition, and nearly 1 million deaths attributed to CVD in the Americas. Hypertension is the major risk factor for CVD, causing half of the cases, and is highly prevalent, affecting one in four adults, including 40% of those over age 25 years. To appropriately detect hypertension, accurate measurement of blood pressure is critical, and inaccurate measurement of BP has important consequences for policies to address hypertension, as well as for patient safety and quality of care. The Fourth World Health Organization (WHO) Global Forum on Medical Devices identified several critical issues related to medical devices. Among those issues were recommendations for increased regulation of medical devices in low- and middle-income countries and development of technical specifications to optimize procurement of priority medical devices. World Health Assembly Resolution 67.20 (Regulatory system strengthening for medical products) stresses the importance of regulation of medical devices for better public health outcomes and to increase access to safe, effective, and quality medical products. This publication seeks to contribute to meeting these recommendations by providing a practical tool for governments to improve their national regulatory frameworks to improve accuracy of blood pressure measuring devices (BPMDs), in turn contributing to the exclusive use of accuracy validated automated BPMDs in primary health care (PHC) facilities by 2025. This publication can also guide the development of procurement mechanisms that will ensure exclusive availability of BPMDs in PHC facilities. Specifically, this publication will provide a brief background on the importance of using validated BPMDs and highlight key elements of regulations related to pre-market approvals to promote accurate BPMDs.

Noncommunicable Diseases and Mental Health; Cardiovascular diseases; Access to Medical Products and Strengthening of Regulatory Capacity; Governance, stewardship and regulation